Related references
Note: Only part of the references are listed.Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Quantitative analysis of highly homologous proteins: the challenge of assaying the CYP-ome by mass spectrometry
Elmar Langenfeld et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Physiology-Based Simulations of a Pathological Condition Prediction of Pharmacokinetics in Patients with Liver Cirrhosis
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2008)
Emerging evidence of the impact of kidney disease on drug metabolism and transport
T. D. Nolin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: Comparison with Korean, Chinese, and Caucasian populations
S. P. Myrand et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
I. S. Song et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Cytochrome P450 turnover: Regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2008)
Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction
Magang Shou et al.
DRUG METABOLISM AND DISPOSITION (2008)
Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling
Z. E. Barter et al.
DRUG METABOLISM AND DISPOSITION (2008)
Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions
Aleksandra Galetin et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling
F. Bouzom et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Pharmacokinetics in drug discovery
Ana Ruiz-Garcia et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry
Gorden Redlich et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems
Valentine C. Ibekwe et al.
PHARMACEUTICAL RESEARCH (2008)
Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements
R. S. Foti et al.
XENOBIOTICA (2008)
A regulatory viewpoint on transporter-based drug interactions
L. Zhang et al.
XENOBIOTICA (2008)
Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man
G. Allan et al.
XENOBIOTICA (2008)
Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin
T. J. Urban et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP (TM)) predicts in vivo metabolic inhibition
Ashok Rakhit et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Diagnosis and differential diagnosis of hypergastrinemia
Rudolf Arnold
WIENER KLINISCHE WOCHENSCHRIFT (2007)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake
M. Baker et al.
XENOBIOTICA (2007)
Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics
Laetitia Comte et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Model-based drug development
R. L. Lalonde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -: CYP2C9 and warfarin as an example
Gemma L. Dickinson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Mechanistic approaches to volume of distribution predictions: Understanding the processes
Trudy Rodgers et al.
PHARMACEUTICAL RESEARCH (2007)
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Amin Rostami-Hodjegan et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Time-dependent CYP inhibition
Robert J. Riley et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Intestinal UGTs as potential modifiers of pharmacokinetics and biological responses to drugs and xenobiotics
Joseph K. Ritter
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: Dextromethorphan as a model application
Gemma L. Dickinson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Ontogeny of human hepatic cytochromes P450
Ronald N. Hines
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2007)
Whole-body physiologically based pharmacokinetic models
Ivan Nestorov
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Proteomic analysis of cytochromes P450: a mass spectrometry approach
Y. Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Population-based assessments of clinical drug-drug interactions: Qualitative indices or quantitative measures?
Honghui Zhou
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans
Wakaba Yamashiro et al.
DRUG METABOLISM AND DISPOSITION (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
The human intestinal cytochrome P450 pie
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2006)
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation
F Ghanbari et al.
CURRENT DRUG METABOLISM (2006)
Prediction of maximum exposure in poor metabolizers following inhibition of nonpolymorphic pathways
C Collins et al.
CURRENT DRUG METABOLISM (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling
Hannah M. Jones et al.
CLINICAL PHARMACOKINETICS (2006)
Changes in liver volume from birth to adulthood: A meta-analysis
TN Johnson et al.
LIVER TRANSPLANTATION (2005)
Impact of the intragastric location of extended release tablets on food interactions
W Weitschies et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
In silico techniques for the study and prediction of xenobiotic metabolism:: A review
SA Kulkarni et al.
XENOBIOTICA (2005)
Tissue distribution of basic drugs:: Accounting for enantiomeric, compound and regional differences amongst β-blocking drugs in rat
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models
B Vrijens et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Techniques: Application of systems biology to absorption, distribution, metabolism, excretion and toxicity
S Ekins et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Bioinformatics in drug development and assessment
DS Wishart
DRUG METABOLISM REVIEWS (2005)
Power, selection bias and predictive performance of the population pharmacokinetic covariate model
J Ribbing et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2004)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
NJ Proctor et al.
XENOBIOTICA (2004)
Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery
CL Stoner et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
MS Faber et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination
LM Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
P-glycoprotein increases from proximal to distal regions of human small intestine
S Mouly et al.
PHARMACEUTICAL RESEARCH (2003)
Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using γ scintigraphy
K Kelly et al.
PHARMACEUTICAL RESEARCH (2003)
Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: Asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers
MD Troutman et al.
PHARMACEUTICAL RESEARCH (2003)
Pharmacokinetics in the newborn
J Alcorn et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
ADMET in silico modelling:: Towards prediction paradise?
H van de Waterbeemd et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Dissolution and absorption modeling: Model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption
KC Johnson
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2003)
Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
YS Lin et al.
MOLECULAR PHARMACOLOGY (2002)
Developmental changes in the expression of enterocytic and hepatic cytochromes P4501A in rat
TN Johnson et al.
XENOBIOTICA (2002)
The effects of portal shunts on intestinal cytochrome P450 3A activity
A Rostami-Hodjegan et al.
HEPATOLOGY (2002)
Physiologically-based pharmacokinetic simulation modelling
GM Grass et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Computer systems for the prediction of xenobiotic metabolism
J Langowski et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution
P Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part II
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts
N Chalasani et al.
HEPATOLOGY (2001)
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
B Agoram et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis
TN Johnson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats
JM DeSesso et al.
FOOD AND CHEMICAL TOXICOLOGY (2001)
Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine
B Olsson et al.
CLINICAL PHARMACOKINETICS (2001)
Progress in predicting human ADME parameters in silico
S Ekins et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Regulation of intestinal blood flow
PJ Matheson et al.
JOURNAL OF SURGICAL RESEARCH (2000)
Share Paper
